FHOD3 deficiency disrupts sarcomere organization and activates caMKII signaling in human stem cell-derived cardiomyocytes
Our study establishes a valuable human-derived model for investigating the molecular mechanisms of FHOD3 deficiency-induced cardiomyopathy. This model allows for extensive investigation into the phenotypes caused by FHOD3 deficiency and identifies CaMKII activation as a crucial factor contributing to the HF phenotype. Additionally, this model serves as an important tool for discovering novel therapeutic agents, and we demonstrate that OM can partially improve myocardial function in FHOD3 KO hESC-CMs.
Authors
- Min Zhu
- Mingyu Wei
- Feng Lan (ORCID: https://orcid.org/0000-0002-1709-5179)
- Ming Cui (ORCID: https://orcid.org/0000-0003-3016-8392)
- Siyao Zhang
- X Y Chen
- Zhan Shi
- X. Y. Hu
- Shuwan Xu
- Xiaojie Hou
- Zhen Gao
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Beijing Anzhen Hospital (CN)
- Peking University Third Hospital (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- Stem Cell Research & Therapy
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1186/s13287-026-04902-z
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 0.00